News

Pfizer COVID-19 Vaccine 90% Effective

Written by Yourway | November 16, 2020

Clinical trial results from Pfizer and BioNTech’s COVID-19 vaccine is thus far 90% effective against coronavirus, beating previous expectations of a 60-70% effectivity rate. Pfizer is still conducting phase III trials, which could impact the overall performance of the vaccine. Yourway is the go-to premium courier for clinical trials and drug product shipments. We handle each shipment on an individual basis, consulting with our clients to determine the best courier service to meet the needs of the trial and patients.